Sophia Genetics Sa · NASDAQ:SOPH

Sophia Genetics Sa — Fact Sheet (October 2024)

2 slides from Sophia Genetics Sa's fact sheet, October 2024

  1. Slide 1: SOPHiA DDM Myeloid Plus Solution

    SOPHiA DDM™ Myeloid Plus Solution The genomic application that streamlines the interpretation of complex variants by combining the DNA target capture and RNA target enrichment kits with the analytical performance and advanced features of the SOPHiA DDM ™ Platform. Main Features Analytical Performanc

  2. Slide 2: RNA Gene Fusion Panel

    RNA Gene Fusion Panel ATF7IP(13)-JAK2(9,11,13,15,17,18,19), BCR(1,4,6,7,12,13,14,19)-ABL1(2,3,4), BCR(1,4,6,7,12,13,14,19)-FGFR1(11), BCR(1,4,6,7,12,13,14,19)-JAK2(9,11,13,15,17,18,19), BCR(1,4,6,7,12,13,14,19)-PDGFRA(12), BMP2K(14,15)-ZNF384(2,3,4,7), CBFA2T3(10,11)-GLIS2(4,5), CBFB(4,5)-MYH11(29,3

SOPHiA GENETICS — Fact Sheet (October 2024) on 6ix